Novartis Ag (NVS) EPS (Basic) (2009 - 2026)
Novartis Ag's EPS (Basic) was $1.68 in Q2 2026, down 15.8% from $1.99 a year earlier but up 3.2% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) EPS (Basic) (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Novartis Ag's EPS (Basic) was $6.57 through Jun 30, 2026, down 2.7% year-over-year; for FY2025, it was $7.20, up 21.8% from FY2024.
- EPS (Basic) shows a five-year compound annual growth rate of 15.2% (FY2020 to FY2025).
- In earlier years, EPS (Basic) was $5.92 in FY2024 (-17.3%), $7.15 in FY2023 (+124.3%), $3.19 in FY2022 (-11.4%) and $3.60 in FY2021 (+1.5%).
- Quarterly EPS (Basic) has moved between $0.67 (Q4 2022) and $7.27 (Q4 2021) over five years.
- Compared with a year earlier, EPS (Basic) has declined for three straight quarters, with growth averaging 9.0% over the last eight quarters.
- The best year-over-year quarter for EPS (Basic) over five years was Q4 2021 (growth of 688.6%); the worst was Q4 2022 (a decline of 90.8%).
- Per Business Quant data, NVS's EPS (Basic) in the three quarters before Q2 2026 was $1.63 (Q1 2026), $1.24 (Q4 2025) and $1.95 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.95 |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 2.30 |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.04 |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -0.54 |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 1.68 |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.62 |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.40 |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -8.44 |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -0.04 |
| 10 | Vertex Pharmaceuticals | 133.33 Bn | 105.34 Bn | 2.84 Bn | 4.34 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.68 |
| Mar 31, 2026 | 1.90 |
| Dec 31, 2025 | 1.17 |
| Sep 30, 2025 | 3.26 |
| Jun 30, 2025 | 2.00 |
| Mar 31, 2025 | 1.81 |
| Dec 31, 2024 | 2.08 |
| Sep 30, 2024 | 3.03 |
| Jun 30, 2024 | 1.56 |
| Mar 31, 2024 | 1.09 |
| Dec 31, 2023 | 4.08 |
| Sep 30, 2023 | 0.85 |
| Jun 30, 2023 | 1.12 |
| Mar 31, 2023 | 1.10 |
| Dec 31, 2022 | 0.67 |
| Sep 30, 2022 | 0.70 |
| Jun 30, 2022 | 0.76 |
| Mar 31, 2022 | 0.99 |
| Dec 31, 2021 | 7.27 |
| Sep 30, 2021 | 1.21 |
API Access
Novartis Ag EPS (Basic) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-basic&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-basic", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-basic&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();